Baseline and dynamic changes in skeletal muscle mass as predictive biomarkers in patients with metastatic renal cell carcinoma treated with Nivolumab: Predictive Value of Sarcopenia in mRCC. Radiol Oncol [Internet]. 2025 Dec. 16 [cited 2026 Oct. 1];59(4):624-3. Available from: https://www.radioloncol.com/index.php/ro/article/view/4685